Selected cutaneous adverse events in patients treated with ICI monotherapy and combination therapy: a retrospective pharmacovigilance study and meta-analysis

by Wenchao Lu, Huiyun Zhang, Qixiang Guo, Zhuoyue Gou, Jiannan Yao
Published 2023-06-01

Effects of Deposition Pressure on the Microstructure,Mechanical Behavior and High-Temperature Oxidation Resistance of AlCrTiSiN Coatings

by GUAN Mengxue, FAN Qixiang, GUO Minglu, ZHANG Shuo, HAO Xuehui, WU Zhenghuan, CAO Fengting, WANG Tiegang
Published 2024-05-01

Pericardial Toxicities Associated With Immune Checkpoint Inhibitors: A Pharmacovigilance Analysis of the FDA Adverse Event Reporting System (FAERS) Database

by Zhuo Ma, Jie Pei, Ximu Sun, Lihong Liu, Wenchao Lu, Qixiang Guo, Jiayou Lyu, Yuwei Liu, Yuhui Zhang, Zhixia Zhao
Published 2021-07-01

The price, efficacy, and safety of within-class targeted anticancer medicines between domestic and imported drugs in China: a comparative analysisResearch in context

by Xingxian Luo, Xin Du, Lin Huang, Qixiang Guo, Ruijie Tan, Yue Zhou, Zhuangqi Li, Xuecai Xue, Taifeng Li, Kaidi Le, Feng Qian, Shein-Chung Chow, Yue Yang
Published 2023-03-01

Evidence of pre-approval clinical trial supporting the granted conditional approval for novel cancer drugs in China between 2015 and 2022Research in context

by Xingxian Luo, Xin Du, Lin Huang, Qixiang Guo, Xufeng Lv, Cen Wang, Haopeng Liu, Yue Zhou, Xuecai Xue, Zhuangqi Li, Jingwen Liu, Shein-Chung Chow, Yue Yang
Published 2023-09-01